Cassava Sciences Inc (SAVA)

$2.07 +0.01 (0.49%)
Market Cap 104.35M
Revenue (ttm) 0.00
Net Income (ttm) -24.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 250,532
Avg Vol 1,097,226
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 54%
Beta -2.04
Analysts Strong Buy
Price Target $2.00

Company Profile

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...

Industry: Biotechnology
Sector: Healthcare
Phone: 512-501-2444
Address:
6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, United States
Jamesnewbie
Jamesnewbie Jul. 16 at 2:37 PM
$KLTO 1. Spiked up to $1.51 before pulling back to $1.31 → indicating a “pump test” signal from the operators. 2. Held above $1.30 despite heavy sell-off → showing support, so even with high outflow, the price didn’t break down. 3. Selling volume > buying volume → this moment is called a “technical wash-out,” allowing the operators to accumulate at cheaper prices. Look back $SAVA so u know how they setup the game play
0 · Reply
Espressuuu
Espressuuu Jul. 15 at 11:16 PM
$SAVA this shit is getting spun-off as an epilepsy drug and you regards are gonna buy into it. do it. please.
1 · Reply
Dkll303
Dkll303 Jul. 15 at 8:26 PM
$CADL similar to $SAVA’s before the FAILED FDA DECISION
1 · Reply
_ICEMAN
_ICEMAN Jul. 15 at 7:38 PM
$SAVA Still holding
1 · Reply
Dkll303
Dkll303 Jul. 15 at 7:07 PM
$QURE still hung up on accounts that copy the truth about QURE ...fcuk even this jade account knows Matt is a FCUK UP .hahaha …and says so Get over the truth before it is another $SAVA ..and $146 to $1.86 !!! Falling …. Oh Ive seen that posted here at $17 !! Guess what ..nothing changes @FundingMyBoat …not even your pathetic rants !! Matt still there ..a ZERO Revenues still don’t pay for manufacturing Losses continue Sounds like a POOR INVESTMENT Smarten up !!!! hahahaah $SAVA …..$SAVA ….$SAVA
0 · Reply
SpencerF
SpencerF Jul. 15 at 1:09 AM
$SAVA have they at least found a few clues on something to make an Alzheimer’s drug or pretty much just at square one brainstorming? Trying various leafs and berries etc?
3 · Reply
movam
movam Jul. 14 at 9:15 PM
$SAVA what are people averages? This never got a spike as it’s typically seen. MM holding it down
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Jul. 14 at 8:31 PM
$SAVA I am still holding this garbage
1 · Reply
lessloss
lessloss Jul. 14 at 8:07 PM
$SAVA only 18 more dollars for me even
0 · Reply
BambooC
BambooC Jul. 14 at 1:41 PM
$SAVA 🤔
0 · Reply
Latest News on SAVA
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Jun 30, 2025, 7:00 AM EDT - 16 days ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

May 1, 2025, 7:30 AM EDT - 2 months ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 21, 2025, 4:30 PM EDT - 3 months ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 26, 2025, 3:49 PM EDT - 3 months ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Mar 25, 2025, 10:42 AM EDT - 4 months ago

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 4 months ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 4 months ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

Feb 9, 2025, 10:45 AM EST - 5 months ago

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Feb 7, 2025, 12:08 PM EST - 5 months ago

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Feb 3, 2025, 5:45 AM EST - 5 months ago

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Jan 23, 2025, 2:47 PM EST - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 6 months ago

Cassava Sciences Provides a Business Update

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

Dec 23, 2024, 5:45 AM EST - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Dec 18, 2024, 10:53 AM EST - 7 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Dec 13, 2024, 1:16 PM EST - 7 months ago

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Bronstein, Gewirtz & Grossman, LLC Encourages Cassava Sciences, Inc. (SAVA) Shareholders to Inquire about Securities Investigation

Dec 10, 2024, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Cassava Sciences, Inc. (SAVA) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect

Dec 9, 2024, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out

Dec 8, 2024, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out

Jamesnewbie
Jamesnewbie Jul. 16 at 2:37 PM
$KLTO 1. Spiked up to $1.51 before pulling back to $1.31 → indicating a “pump test” signal from the operators. 2. Held above $1.30 despite heavy sell-off → showing support, so even with high outflow, the price didn’t break down. 3. Selling volume > buying volume → this moment is called a “technical wash-out,” allowing the operators to accumulate at cheaper prices. Look back $SAVA so u know how they setup the game play
0 · Reply
Espressuuu
Espressuuu Jul. 15 at 11:16 PM
$SAVA this shit is getting spun-off as an epilepsy drug and you regards are gonna buy into it. do it. please.
1 · Reply
Dkll303
Dkll303 Jul. 15 at 8:26 PM
$CADL similar to $SAVA’s before the FAILED FDA DECISION
1 · Reply
_ICEMAN
_ICEMAN Jul. 15 at 7:38 PM
$SAVA Still holding
1 · Reply
Dkll303
Dkll303 Jul. 15 at 7:07 PM
$QURE still hung up on accounts that copy the truth about QURE ...fcuk even this jade account knows Matt is a FCUK UP .hahaha …and says so Get over the truth before it is another $SAVA ..and $146 to $1.86 !!! Falling …. Oh Ive seen that posted here at $17 !! Guess what ..nothing changes @FundingMyBoat …not even your pathetic rants !! Matt still there ..a ZERO Revenues still don’t pay for manufacturing Losses continue Sounds like a POOR INVESTMENT Smarten up !!!! hahahaah $SAVA …..$SAVA ….$SAVA
0 · Reply
SpencerF
SpencerF Jul. 15 at 1:09 AM
$SAVA have they at least found a few clues on something to make an Alzheimer’s drug or pretty much just at square one brainstorming? Trying various leafs and berries etc?
3 · Reply
movam
movam Jul. 14 at 9:15 PM
$SAVA what are people averages? This never got a spike as it’s typically seen. MM holding it down
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Jul. 14 at 8:31 PM
$SAVA I am still holding this garbage
1 · Reply
lessloss
lessloss Jul. 14 at 8:07 PM
$SAVA only 18 more dollars for me even
0 · Reply
BambooC
BambooC Jul. 14 at 1:41 PM
$SAVA 🤔
0 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 14 at 12:48 AM
$NUVB $TNXP so are these two @BioCapitalist99 … the bull and the triceratops 🐂 🦖 🚀 My #1 and #3 biotech holdings. I avoided $CAPR $INMB $SAVA - thank goodness 😅 Patients are waiting ⏰
1 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 13 at 4:15 PM
$INMB dead cat bounce. Hate to admit it but @martinshkreli2015 nailed this short just like $SAVA and $CAPR
2 · Reply
NeverBearTrader2025
NeverBearTrader2025 Jul. 12 at 7:55 PM
$ALT Even people who hold a lot of shares here secretely bash and talk down on the stock. I've never seen crazy like these before. $SAVA board and retail holder are way better.
2 · Reply
WhosYourDaddy_
WhosYourDaddy_ Jul. 11 at 8:27 PM
$SAVA I just wanted to stop by and let you guys know. Tiffany said hello.
1 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 11 at 5:37 PM
$CAPR another scalp for @martinshkreli2015 . He also nailed $INMB & $SAVA too. He was a terrible CEO and the kind of price gouging he pulled on Daraprim should be illegal. Watch out $AVXL . He has you on his list - but will be correct 4 straight times? 🧐
4 · Reply
SpencerF
SpencerF Jul. 11 at 3:30 PM
$SAVA company pretty much done?
1 · Reply
MaverikIT
MaverikIT Jul. 11 at 2:36 PM
$SAVA - da faacck - fooking on spiked kool-aid ? 'middle' finger
0 · Reply
BambooC
BambooC Jul. 11 at 2:08 PM
$SAVA 🤔
1 · Reply
dadatr8der
dadatr8der Jul. 11 at 1:41 PM
$SAVA 💯
0 · Reply
38ckent
38ckent Jul. 10 at 8:16 PM
$AVXL I remember back in June 2021 when we ran to almost $30 and I thought we were going to get our $SAVA moment but, to my disappointment, we didn't and $ANVS got it instead. Now we know what happened to those companies so it's probably good we didn't get it then. It's coming and it's going to be the real deal. We have the science, the patients, the data and the Alzheimer's experts backing us up. EMA approval on the horizon. Unlike the others, there's no looking back when it comes!
3 · Reply
bigron8671
bigron8671 Jul. 10 at 6:39 PM
$SAVA same show
0 · Reply
dadatr8der
dadatr8der Jul. 10 at 3:59 PM
$SAVA 💯
0 · Reply